These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7125700)

  • 21. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors.
    Stierer M; Rosen H; Weber R; Hanak H; Spona J; Tüchler H
    Ann Surg; 1993 Jul; 218(1):13-21. PubMed ID: 8328824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery.
    Greenberg R; Barnea Y; Schneebaum S; Kashtan H; Kaplan O; Skornik Y
    Isr Med Assoc J; 2003 Sep; 5(9):649-52. PubMed ID: 14509156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of measuring hormone receptor levels of regional metastatic carcinoma of the breast.
    Butler JA; Trezona T; Vargas H; State D
    Arch Surg; 1989 Oct; 124(10):1131-4; discussion 1134-5. PubMed ID: 2802974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors].
    Reiner G; Jakesz R; Kolb R; Kühnl-Brady K; Reiner A; Schemper M; Spona J
    Dtsch Med Wochenschr; 1988 Jun; 113(22):892-7. PubMed ID: 3371221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p29 protein in breast cancer: relation between estrogen and progesterone receptors.
    Artero Morà A; Lluch Hernandez A; Cano Sanchez A; Bueno Cañigral FJ; Martin Quetglas G; Alberola Candel V; Garcia-Conde Bru J
    Tumori; 1989 Apr; 75(2):113-6. PubMed ID: 2741216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group.
    Kinne DW; Butler JA; Kimmel M; Flehinger BJ; Menendez-Botet C; Schwartz M
    Arch Surg; 1987 Nov; 122(11):1303-6. PubMed ID: 3675194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading.
    Parl FF; Schmidt BP; Dupont WD; Wagner RK
    Cancer; 1984 Nov; 54(10):2237-42. PubMed ID: 6488142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor protein in breast cancer as a predictor of recurrence.
    Kinne DW; Ashikari R; Butler A; Menendez-Botet C; Rosen PP; Schwartz M
    Cancer; 1981 May; 47(10):2364-7. PubMed ID: 7272892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor assay in primary breast cancer and early recurrence of the disease.
    Maynard PV; Blamey RW; Elston CW; Haybittle JL; Griffiths K
    Cancer Res; 1978 Nov; 38(11 Pt 2):4292-5. PubMed ID: 698968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients.
    Crowe JP; Hubay CA; Pearson OH; Marshall JS; Rosenblatt J; Mansour EG; Hermann RE; Jones JC; Flynn WJ; McGuire WL
    Breast Cancer Res Treat; 1982; 2(2):171-6. PubMed ID: 7171837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The correlation between estrogen and progesterone receptors and some clinical and pathological features in human breast cancer.
    Caldarola L; Volterrani P; Lai M; Vigezzi P; Gaglia P
    Ital J Surg Sci; 1985; 15(4):329-33. PubMed ID: 3830952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
    Bogina G; Lunardi G; Coati F; Zamboni G; Gori S; Bortesi L; Marconi M; Cassandrini PA; Turazza M; Cortesi L; DeMatteis E; Ficarra G; Ibrahim T; Serra P; Medri L; Giraudi S; Lambertini M; Carli F; Foglietta J; Sidoni A; Nunzi M; Ficorella C; Diadema MR; Del Mastro L
    Tumori; 2015; 101(4):398-403. PubMed ID: 26045108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen and progesterone receptor profile patterns in primary breast cancer.
    Thorpe SM; Rose C; Pedersen BV; Rasmussen BB
    Breast Cancer Res Treat; 1983; 3(1):103-10. PubMed ID: 6871479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proliferation index, axillary lymph node status, hormone receptors and age as prognostic factors in primary breast cancer].
    Kaufmann M; Klinga K; Kühn W; Abel U
    Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():104-8. PubMed ID: 2703135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol and progesterone receptors in breast cancer: prognostic value after relapse.
    Bonneterre J; Horner D; Peyrat JP; Vandewalle B; Cambier L; Demaille A
    Breast Cancer Res Treat; 1985; 5(2):149-54. PubMed ID: 4016280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.